Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Dermatology
»
Skin Neoplasms
»
Melanoma
26. November 2025
Search
medline.ch
Melanoma
Advanced search
Dermatology
Acne
Alopecia
Dermatitis
Infectious Skin Diseases
Photosensitivity Disorder
Psoriasis
Skin Neoplasms
Melanoma
Others
Skin Ulcer
Urticaria
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 2213
Articles 1 - 20 / 44241
"Response to Factors associated with adherence to skin self-examination recommendations for melanoma patients: a prospective cohort study".
J Am Acad Dermatol
Gill M, Yang S, Kim D, Babaei N, Cervantes M, Wu JJ.
PMID: 41285263 [PubMed - as supplied by publisher]
Does tattoo exposure increase the risk of cutaneous melanoma? A population-based case-control study.
Eur J Epidemiol
Rietz Liljedahl E, Nielsen K, Engfeldt M, Saxne Jöud A, Nielsen C.
PMID: 41284183 [PubMed - as supplied by publisher]
Is Radiotherapy a Risk Factor for Melanoma?
Dermatopathology (Basel)
Ozer S, Agarwal P, Musolff N, Plann-Curley B, Cosgun G, Sun HY, Rao B.
PMID: 41283485 [PubMed]
Translating Features to Findings: Deep Learning for Melanoma Subtype Prediction.
Dermatopathology (Basel)
Guermazi D, Khemchandani S, Wahood S, Nguyen C, Saliba E.
PMID: 41283484 [PubMed]
The mediating role of rumination between fear of disease progression and sleep disturbance in melanoma patients: a dual-perspective analysis based on person-centered and variable-centered approaches.
Front Public Health
Huang Q, Yue F, Shi W, Lei Y, Jiang T.
PMID: 41283030 [PubMed - indexed for MEDLINE]
Lead-in therapy targeting PD1 and/or LAG3 imposes distinct immune phenotypes in first-line treatment of metastatic melanoma.
medRxiv
Karapetyan L, Cillo AR, Wang S, Karunamurthy A, Massa RC, Rohatgi A, Deitrick C, Najjar YG, Davar D, Luke JJ, Sander C, Kunning SR, Rose A, Bradley S, Rush E, Joy M, Bao R, Wang H, Vignali DAA, Bruno TC, Kirkwood JM.
PMID: 41282765 [PubMed]
Deep learning [(18)F]-FDG-PET/CT‑based algorithm for tumor burden estimation in metastatic melanoma patients under immunotherapy.
Clin Transl Radiat Oncol
Faro LL, Gabry, Burgermeister S, Abler D, Fritsak M, Ahmadsei M, Franzese C, Depeursinge A, Cuendet MA, Tanadini-Lang S, Balermpas P, Scorsetti M, Guckenberger M, Christ SM.
PMID: 41281625 [PubMed]
Navigating the Rare: (18)F FDG PET/CT Reveals Uterine Metastasis from Cutaneous Melanoma.
Indian J Nucl Med
Subramani R, Selvam V, Singh V, Abhilash S.
PMID: 41281177 [PubMed]
Iron oxide nanoparticles empowering melanoma therapy: advances in multifunctional platform research.
Front Bioeng Biotechnol
Bai X, Wang Z, Cao Z, Zhen J.
PMID: 41280655 [PubMed]
Sex disparities in melanoma stage, recurrence and mortality: AÂ Danish cohort study, 2004 to 2024.
J Eur Acad Dermatol Venereol
Lyngstrand JE, Røssell EL, Bønnelykke-Behrndtz ML, Laurberg T.
PMID: 41277769 [PubMed - as supplied by publisher]
Disparities in Cutaneous Melanoma Diagnosis and Survival Among American Indian and Alaskan Native Patients: A Systematic Review and Meta-Analysis.
J Surg Oncol
Li RA, Nguyen AT, Bajaj K, Coles BM, Galiano RD.
PMID: 41277703 [PubMed - as supplied by publisher]
The application of 3D cell culture for melanoma in vitro models.
Acta Biomater
Xu K, Wu J, Li Z, Chen W, Wei P, Wu M.
PMID: 41275949 [PubMed - as supplied by publisher]
Cellular senescence related gene signature predicts prognosis and immune features in skin cutaneous melanoma.
Discov Oncol
Li M, Cen X, Yan Y, Li L, Lai W.
PMID: 41275062 [PubMed - as supplied by publisher]
Sex and gender influence on adverse events for melanoma patients: a comprehensive review and meta-analysis.
Br J Cancer
Gaeta A, Nuvoli L, Doccioli C, Caini S, Saponara M, Cimminiello C, Cosma C, Palmieri G, Cossu A, Vicini F, Mazzarella L, Tosti G, Queirolo P, Gandini S.
PMID: 41275011 [PubMed - as supplied by publisher]
Prognostic value of a combined model integrating clinical and PET radiomics parameters in metastatic melanoma: A dual-center retrospective study.
Ann Nucl Med
Lai R, Jiang Z, Sheng D, Geng Y, Tan Q, Ding C, Teng Y, Zhou Z.
PMID: 41273608 [PubMed - as supplied by publisher]
Real-world management of adjuvant systemic melanoma therapy: Multi-center survey of 51 DeCOG skin cancer centers.
J Dtsch Dermatol Ges
Reitmajer M, Livingstone E, Heinzerling L, Thoms KM, Meiss F, Heppt MV, Gesierich A, Drexler K, Meier F, Schlaak M, Forschner A, Zimmer L.
PMID: 41273148 [PubMed - as supplied by publisher]
The Potential of Phytochemicals to Overcome Multidrug Resistance in Metastatic Melanoma.
Chem Biodivers
Maphutha J, Twilley D, Dawood M, Efferth T, Lall N.
PMID: 41270229 [PubMed - as supplied by publisher]
The use of an acellular wound matrix for Mohs surgical reconstruction: a case series.
Wounds
Ansert EA, Thornton JF, Du A, Thornton A, Kim PJ.
PMID: 41270198 [PubMed - indexed for MEDLINE]
Soluble HLA-G is related to malignant melanocytic lesions and previous oncological disease may increase circulating HLA-G bearing large extracellular vesicles.
Front Immunol
Silva-Krebs KK, de Oliveira EM, Athayde CA, da Fonseca PB, De Felice FG, Carvalho FR, Sá Araújo M, Luz FB, Silva AA, Pantaleão L, Medeiros T, Dayse-Silva IL.
PMID: 41268555 [PubMed - indexed for MEDLINE]
Letter response to Sutcliffe et al. ("Re: Single modality indocyanine green is feasible for sentinel node detection in head and neck cutaneous melanoma: A prospective cohort study").
J Plast Reconstr Aesthet Surg
Vyas R, Jones C, Harper Machin A.
PMID: 41266195 [PubMed - as supplied by publisher]
Articles 1 - 20 / 44241
Page 1 of 2213
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy